483 Hangzhou Zhongmei Huadong Pharmaceutical Aug 2018

483 Hangzhou Zhongmei Huadong Pharmaceutical Aug 2018

Christopher Middendorf FDA, Huiquan Wu FDA$119.00 - Available Now

FDA investigators audited the Hangzhou Zhongmei Huadong Pharmaceutical - Hangzhou, China facility and issued inspectional observations (via FDA 483) on 23 Aug 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Aug 2018
  • Location: Hangzhou, China
  • FEI: 3003995556
Add To Cart